Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2009
11/04/2009CN101573343A HIV inhibiting 6-substituted pyrimidines
11/04/2009CN101573342A HIV inhibiting 5,6-substituted pyrimidines
11/04/2009CN101573339A Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation
11/04/2009CN101573336A Chemical compounds
11/04/2009CN101573335A Kinase inhibitors
11/04/2009CN101573333A Inhibitors of histone deacetylase
11/04/2009CN101573131A Anti-connexin compounds and uses thereof
11/04/2009CN101573111A Formulations of phospholipase enzyme inhibitors
11/04/2009CN101573108A Particles of paclitaxel and albumin in combination with bevacizumab against cancer
11/04/2009CN101573033A Heterocyclyl-substituted anti-hypercholesterolemic compounds
11/04/2009CN101570528A Glycyrrhizin derivatives and preparation and use thereof
11/04/2009CN101570517A 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
11/04/2009CN101570510A Quinoline compound, pharmaceutical composition, preparation method and application thereof
11/04/2009CN101569631A Anti tumor application of 3-carbonyl-20alpha-hydroxy-24-en-dammarane compound
11/04/2009CN101569612A Lyophilized clindamycin phosphate powder needle reagent
11/03/2009US7612238 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases
11/03/2009US7612225 Endothelin receptor antagonist, useful for treating various circulatory system diseases such as hypertension, ischemic disorders, cerebral circulatory disorders, renal disorders, circulatory insufficiency of various organs, asthma, stroke
11/03/2009US7612219 11—[ (Z) -3- (dimethylamino) propylidene]—6, 11-dihydro-dibenz [B,E] oxepin-2-YI ]—acetic acid
11/03/2009US7612213 (E)-ethyl 7-hydroxy-2-methyl-2-heptenate; (3E, 5E)-tert-butyl-9-(tert-butyldimethylsiloxy)-2-[(E)-ethylid ene]-4-methylnona-3,5-dienate
11/03/2009US7612212 Substituted hydantoins
11/03/2009US7612211 TRPV1 ion channel mediated disease; chronic or acute pain, inflammatory pain, burning pain or post-operative pain; 2-[2-(4-trifluoromethyl-phenoxymethyl)-1H-benzoimidazol-5-yl]-benzenesulfonamide
11/03/2009US7612206 Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors
11/03/2009US7612202 Process for preparing temozolomide
11/03/2009US7612201 Pyrazole compounds
11/03/2009US7612198 Low reducing sugar content, high level of alpha glucoside bonds, narrow range of high molecular weights, specific branched chain length distribution profile; low intrinsic viscosity; food, and medical applications
11/03/2009US7612185 Nucleic acid biosensors
11/03/2009US7612115 Citric acid, polyethylene glycol, and ofloxacin; low gelation temperatures; bioavailability
11/03/2009US7612114 Selective estrogen receptor modulator
11/03/2009US7612113 Hydroxy tetrahydro-naphthalenylurea derivatives
11/03/2009US7612111 Esterified fatty acid composition
11/03/2009US7612110 Immunosuppressants; for use in transplantation medicine or treatment of autoimmune diseases such as polyarthritis but not psoriatitc arthritis; micro-tablets, pellets
11/03/2009US7612109 Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes
11/03/2009US7612108 2-phenylthiophene derivative
11/03/2009US7612107 Such as cancer, diabetes, hemophilia, liver disease, diseases involving human aldehyde dehydrogenase 2, polycystic kidney disease, lysosomal storage diseases, high cholesterol, obesity, high triglycerides, glycoprotein metabolism, and angiogenesis
11/03/2009US7612106 Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof
11/03/2009US7612105 3-arylphenyl sulfide derivative and insecticide and miticide
11/03/2009US7612104 Peroxisome proliferator-activated receptor agonists; insulin resistance; neurodegenerative diseases
11/03/2009US7612103 Such as 14-O-[4-hydroxy-N-valyl-piperidin-3-yl]-sulfanylacetylmutilin
11/03/2009US7612102 Pre-mixed, ready-to-use pharmaceutical compositions
11/03/2009US7612100 Anthranilamides, process for the production thereof, and pest controllers containing the same
11/03/2009US7612099 Such as 3-[(5-Fluoro-3-methyl-1H-indol-2-yl)-phenyl-methyl]-4-hydroxy-5-isopropyl-1,5-dihydro-pyrrol-2-one which inhibits chymase
11/03/2009US7612098 Amorphous hydrous esomeprazole magnesium
11/03/2009US7612097 Microbiocidal; cost efficiency; industrial scale
11/03/2009US7612096 Methods for treatment, modification and management of radiculopathy using 1-oxo-2-(2,6-dioxopiperidin-3yl)-4-aminoisoindoline
11/03/2009US7612095 Polymorph of 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1-piperidinyl]ethyl]-αα-dimethyl-benzeneacetic acid
11/03/2009US7612094 Tri-substituted heteroaryls and methods of making and using the same
11/03/2009US7612093 With (-)-2'-deoxy-3'-thiocytidine-5'-triphosphate; immunomodulators; nucleosides
11/03/2009US7612092 Nitrogen-containing aromatic derivatives
11/03/2009US7612091 Caspase inhibitors and uses thereof
11/03/2009US7612090 Use in treatment of a disorder which is created by or is dependent upon decreased availability of serotonin, norepinephrine or dopamine
11/03/2009US7612089 N-[4-(1-methyl-4,5-dihydro-1H-imidazol-2-yl)phenyl]-2N-(4-chlorophenylaminocarbonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide; thrombosis; inhibits coagulation of a blood sample
11/03/2009US7612088 Heterocyclic compounds and their use as aldosterone synthase inhibitors
11/03/2009US7612087 Heterocyclic compounds as inhibitors of beta-lactamases
11/03/2009US7612086 Jun N-terminal kinase inhibitors; 1H-pyrrolo[2,3-b]pyridines 3-substituted with a C 5-7 carbocycle and 5-substituted by a 5-member heterocycle; 3-(p-(dimethylamino)phenyl)-5-(2-thiazolyl-1H-pyrrolo[2,3-b]pyridine; neurodegenerative disorders related to apoptosis and/or inflammation
11/03/2009US7612085 N-(9-(6-aminohexyl)-9-azabicyclo[3.3.1]nonan-3 alpha-yl)-N'-(2-methoxy-5-methylphenyl)carbamate or corresponding 9-(p-dimethylaminobenzyl) compound, and a (m-bromophenyl)ethyl-nortropane compound; probes to the sigma 2 receptor; anticancer agents, antitumor agents, use with other chemotherapeutic agents
11/03/2009US7612084 5-[(1R)-2-({2-[4-(4-{3-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-hydroxyphenyl}butoxy)phenyl]ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1H)-one; chronic obstructive pulmonary disease (COPD), allergies
11/03/2009US7612083 Urea substituted imidazoquinoline ethers
11/03/2009US7612081 Such as tert-butylester of 20S-(4-{[3-(7-camptothecinylidene-amino)-propyl]-tert-butoxycarbonyl-amino}-butyl)-(3-tert-butoxycarbonylaminopropyl)-carbamic acid; topoisomerase I inhibiting activity and useful for treatment of tumors and viral and parasite infections
11/03/2009US7612080 GTPase inhibitors and use thereof for controlling platelet hyperactivity
11/03/2009US7612079 2-(hydroxypiperidin-1-yl or hydroxyisoalkylamino)-6(3-nitrophenylamino, 3,4-dimethoxybenzylamino, pyrid-2-yl-methylamino, pyrid-4-yl-methylamino or indan-5-amino)-9-(isopropyl or cyclopentyl)purines; cell cyclin kinase inhibitors for treating cancer, leukemia, psoriasis and neuronal apoptosis
11/03/2009US7612078 Piperidinylamino-thieno[2,3-D] pyrimidine compounds
11/03/2009US7612077 Crystalline forms of the anti-cancer compound ZD1839
11/03/2009US7612076 For treatment and/or prevention of diseases which are associated with the modulation of H3 receptors; obesity; N-[2-(4-ethyl-piperazin-1-yl)-pyridin-4-yl]-C-phenyl-methanesulfonamide; C-(4-chloro-phenyl)-N-[2-(4-ethyl-piperazin-1-yl)-pyridin-4-yl]-methanesulfonamide
11/03/2009US7612075 Anticaogulants; cardiovascular disorders
11/03/2009US7612074 Diazabicyclic aryl derivatives as cholinergy ligands
11/03/2009US7612073 For administration with food; bioavailability
11/03/2009US7612072 Dihydrogenphosphate salt of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3- alpha ]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine; diabetes, obesity, and high blood pressure
11/03/2009US7612071 treating a disorder in a pediatric patient with an antifolate having greater interpatient oral bioavailability than methotrexate including variability in therapeutic index, in toxicity, efficacy in combination therapy, and efficacy of certain polyglutamates
11/03/2009US7612070 Indole derivative having heterocycle and mono- or diazaindole derivative
11/03/2009US7612069 Acyl guanidines as beta-secretase inhibitors
11/03/2009US7612068 (S)-1-{2-[2-(4-Fluoro-phenylsulfanyl)-phenoxy]-ethyl}-pyrrolidine-2-carboxylic acid; glycine transport inhibitors; for schizophrenia and other psychoses
11/03/2009US7612067 Imidazopyridazine compounds
11/03/2009US7612066 1-(3-tert-butyl-4-methoxy-5-morpholinophenyl)-2-(5,6-diethoxy-7-fluoro-1-imino-1,3-dihydroisoindol-2-yl)ethanone,; stabilizing the composition; not decompose even when placed under humidification conditions
11/03/2009US7612065 Fused n-heterocylic derivatives; mitogen-activated protein kinase inhibitors; Parkinson's disease
11/03/2009US7612064 Sulfopyrroles
11/03/2009US7612063 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 4-oxo-4H-pyrido[3,2,1-kl]benzo[g]-phenoxazine for example; Tumor suppression agents with reduced side effects; anticancer
11/03/2009US7612062 Pyrrolobenzodiazepines
11/03/2009US7612061 trans-1-{2-[(3,5-dibromobenzyl)oxy]-1,2,3,4-tetrahydronaphth-1-yl}-1,4-diazepane; serotonin reuptake inhibitor and/or neurokinin NK1 antagonist; antidepressant, anxiolytic agent; cognition activator; psychological disorders; obesity, gastrointestinal disorders
11/03/2009US7612060 (R)-3-((1-((R)-7-cyclopropylaminomethyl-3,4-dihydro-2H-chromen-4-yl)-1H-1,2,3-triazol-4-yl)methyl)-4-(4-methylbenzenesulfonyl)-3,4-dihydropyrazin-2(1H)-one; pain, inflammation
11/03/2009US7612059 Pyrrolidine bicyclic compounds and its derivatives, compositions and methods of use
11/03/2009US7612058 Administering 1-(4-fluorophenyl)-3(R)-[3(S)-(4-fluorophenyl)-3-hydroxypropyl)]-4(S)-[4-(phenylmethoxy)phenyl]-2-azetidinone; and peroxisome proliferator-activated receptor activator; obesity, antidiabetic agents
11/03/2009US7612057 Antiproliferative agents; leukemia
11/03/2009US7612056 Substituted diaza-spiro-[4.5]-decane derivatives and their use as neurokinin antagonists
11/03/2009US7612055 Macrocyclic lactams and pharmaceutical use thereof
11/03/2009US7612054 Dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
11/03/2009US7612053 7-Substituted fused ring tetracycline compounds
11/03/2009US7612052 Combinations comprising epothilones and pharmaceutical uses thereof
11/03/2009US7612051 Silicone having alcoholic hydroxyl groups; little cohesion, excellent dispersibility and excellent stability over time
11/03/2009US7612050 Via bisphosphonate drug; for prophylaxis of cartilage destruction or chondrolysis associated with osteonecrosis and/or osteochondritis dissecans
11/03/2009US7612047 Degradation-resistant mononucleoside phosphate compounds
11/03/2009US7612045 Compounds, compositions and methods for controlling biofilms and bacterial infections
11/03/2009US7612042 Using soluble isoform of estrogen receptor as heregulin inhibiting therapeutic for use in treatment and prevention of breast and prostate cancer; competitive binding; gene therapy
11/03/2009US7612037 Vancomycin coupled through an oxime to and aminochlorothiazolo pyridinium substituted bicyclic hetero ring; antibiotics
11/03/2009US7612035 Inhibition of mitogen-activated protein kinase (MAPK) pathway: a selective therapeutic strategy against melanoma
11/03/2009US7612034 Administering calcitonin and dehydroepiandrosterone (DHEA) to patient being treated for systemic lupus erythematosus where the immunosuppressant tends to reduce bone mineral density(BMD); osteoporosis
11/03/2009US7611910 Determining whether cerebralspinal fluid sample contains Chlamydia pneumoniae
11/03/2009US7611865 Genetic engineering
11/03/2009US7611843 Testing a compound for its ability to interupt a tmRNA structural domain selected from a H2 helix, a H5 helix, a PK1 pseudoknot, a PK2 pseudoknot, a PK3 pseudoknot or a PK4 pseudoknot to identify a drug candidate for treating a bacterial infection
11/03/2009US7611830 Device to lavage a blood vessel
11/03/2009US7611733 Solid Lipid Nanoparticles comprising a hydrophilic platinum complex comprising anionic ligands and ligands containing amino groups such as trans-{bis[trans(diammine)(chloro)platinum (II) ( mu -1,6-hexanediamine)]}diammineplatinum tetranitrate salt
1 ... 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 ... 7860